Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
Cipla faces fresh FDA blow, Pune warehouse drug licences cancelled - Rediff.com India News
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) warehouse in Pune. This action follows alleged violations related to packaging, storage, documentation, and recall of Reactin Plus Tablets, a Schedule H drug. The FDA cited issues like misbranding, inadequate storage conditions, and deficiencies in record-keeping, reiterating its commitment to ensuring medicine safety and compliance.
Ähnliche Seiten
Maharashtra FDA Cancels Cipla's Pune Warehouse Drug Licences Over Alleged Packaging, Storage & Record Violations
https://www.freepressjournal.in/pune/maharashtra-fda-cancels-ciplas-pune-warehouse-drug-licences-over-alleged-packaging-storage-record-violationsMaharashtra FDA Cancels Cipla Pharma & Life Sciences’ Pune Warehouse Drug Licences Over Multiple Lapses
https://www.freepressjournal.in/mumbai/maharashtra-fda-cancels-cipla-pharma-life-sciences-pune-warehouse-drug-licences-over-multiple-lapses
Maharashtra FDA cancels Cipla's Pune warehouse licences over Reactin Plus packaging claims - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/maharashtra-fda-cancels-cipla-warehouse-licences-over-drug-violations/articleshow/134641214.cms